Hernia mesh claims: who can file and what to do in Texas

Texas plaintiffs in hernia mesh litigation are primarily directed to Davol/CR Bard MDL 2846 in S.D. Ohio before Judge Edmund Sargus, which had 23,324 pending actions as of Oct. 1, 2026 (JPML) and represents the central federal forum for Bard Davol products. Covidien cases were centralized in MDL 3029 in the District of Massachusetts before Judge Patti B. Saris. Atrium C-QUR plaintiffs proceed in MDL 2753 (D.N.H.), and Ethicon/J&J plaintiffs file in the Atlantic County NJ state court mass tort.

Texas imposes a two-year statute of limitations on products liability claims under the Texas Civil Practice & Remedies Code. The discovery rule applies: the limitations period does not begin until a plaintiff knew or should have known that the mesh caused the injury. Mesh injuries — recurrence, bowel obstruction, infection, erosion, and chronic pain — often become diagnosable only years after surgery, making the discovery rule outcome-determinative for many Texas claimants.

Texas is a high-volume surgical state, with major mesh implant activity concentrated in Houston, Dallas-Fort Worth, San Antonio, and Austin. The large elderly and active-labor population elevates hernia repair rates. CR Bard Davol products (Ventralight, PerFix, Marlex) and Covidien Parietex products carry the heaviest defendant product distribution in Texas.

Texas plaintiffs with Ethicon Physiomesh or Prolene Hernia System claims should note that J&J has successfully argued for state court consolidation in Atlantic County, NJ rather than inclusion in any federal MDL. Texas counsel should coordinate with NJ-licensed co-counsel to file directly in the Atlantic County mass tort program.